Zimmer Biomet Holdings (ZBH) Common Equity (2009 - 2026)

Zimmer Biomet Holdings' Common Equity history runs 18 years deep, the most recent figure standing at $12.7 billion for Q1 2026.

• On a quarterly basis, Common Equity rose 2.24% year-over-year to $12.7 billion in Q1 2026; TTM through Mar 2026 was $12.7 billion, a 2.24% increase from a year earlier, with the FY2025 full-year figure at $12.7 billion, up 1.84% from the prior year.
• Common Equity held at $12.7 billion in Q1 2026 per ZBH's latest filing, from $12.7 billion in the prior quarter.
• Across five years, Common Equity topped out at $12.8 billion in Q3 2025 and bottomed at $12.0 billion in Q1 2022.
• The 5-year median for Common Equity is $12.5 billion (2024), against an average of $12.4 billion.
• Across the five-year window, Common Equity decreased 5.05% in 2022 and increased 3.83% in 2023, its largest moves.
• Year by year, Common Equity stood at $12.0 billion in 2022, then climbed by 3.83% to $12.5 billion in 2023, then slipped by 0.1% to $12.5 billion in 2024, then gained by 1.84% to $12.7 billion in 2025, then slipped by 0.19% to $12.7 billion in 2026.
• Per Business Quant, the three latest ZBH Common Equity figures stand at $12.7 billion (Q1 2026), $12.7 billion (Q4 2025), and $12.8 billion (Q3 2025).